Asperosaponin VI
CAS: 39524-08-8
Ref. 3D-FA73822
25mg | Discontinued | ||
50mg | Discontinued | ||
100mg | Discontinued | ||
250mg | Discontinued | ||
500mg | Discontinued |
Product Information
- 3-O-α-<span class="text-smallcaps">L</smallcap>-Arabinopyranosylhederagenin 28-O-β-<smallcap>D</smallcap>-glucopyranosyl-(1→6)-β-<smallcap>D</span>-glucopyranoside
- Hederagenin 3-O-alpha-L-arabinopyranosyl-28-beta-D-glucopyranosyl-beta-D-glucopyranoside
- Hederagenin 3-O-α-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl-28-β-<smallcap>D</smallcap>-glucopyranosyl(1→6)-β-<smallcap>D</span>-glucopyranoside
- Leiyemudanoside A
- Olean-12-en-28-oic acid, 3-(α-<span class="text-smallcaps">L</smallcap>-arabinopyranosyloxy)-23-hydroxy-, 6-O-β-<smallcap>D</smallcap>-glucopyranosyl-β-<smallcap>D</span>-glucopyranosyl ester, (3β,4α)-
- Tauroside St-G<sub>0-1</sub>
Asperosaponin VI is a saponin with potent anti-inflammatory properties. It has been shown to inhibit the lps-induced inflammatory response in macrophages and induces neuronal death in rat primary cortical neurons. Asperosaponin VI also protects against hepatic steatosis and bowel disease. This natural compound binds to the mitochondrial membrane potential and inhibits the polymerase chain reaction, which is responsible for DNA replication. The optimal concentration of Asperosaponin VI for treatment of various diseases is dependent on the cell type studied, but ranges from 10 µg/mL to 100 µg/mL.